Skip to content
StockMarketAgent
Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

HSCS stock hub

HeartSciences Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

HSCSis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
6.1M
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
HSCS
In the news

Latest news · HSCS

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.3P50 18.4P75 33.1
Trailing P/En/a
P25 14.9P50 23.2P75 38.5
ROE-382.3
P25 -105.6P50 -46.5P75 -3.1
ROIC-86.3
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All HSCS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
196
Groups with data
11
Currency
USD
Showing 196 of 196 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

25
MetricValue
Cik
0001468492
Company name
HeartSciences Inc.
Country
United States
Country code
US
Cusip
42254E104
Employees
15
Employees Change
3%
Employees Change Percent
25
Enterprise value
$6.6M
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Medical Devices
IPO Date
2022-06-15
Isin
US42254E3027
Last refreshed
2026-05-10
Market cap
$6.1M
Market cap category
Nano-Cap
Price
$1.94
Price currency
USD
Rev Per Employee
577.93x
Sector
Healthcare
Sic
3842
Symbol
HSCS
Website
https://heartsciences.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

5
MetricValue
Earnings Yield
-137.99%
EV/Sales
763.55x
FCF yield
-119.44%
P/B ratio
2.32x
P/S ratio
709.33x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

13
MetricValue
Gross margin
57.92%
Gross Profit
$5,021
Gross Profit Growth3 Y
-1.31%
Net Income
$-8.5M
Net Income Growth Quarters
1%
Net Income Growth Years
0%
Pretax Margin
-97,880.97%
Profit Per Employee
$-565,687
ROA
-73.51
Roa5y
-101.8
ROCE
-237.3
ROE
-382.3
ROIC
-86.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

7
MetricValue
Cagr1y
-43.95%
Cagr3y
-71.95%
EPS Growth Quarters
3
EPS Growth Years
3
Revenue Growth
-76.61x
Revenue Growth Years
0x
Revenue Growth3 Y
-2.31x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

18
MetricValue
Asset Turnover
$0
Assets
$7.6M
Cash
$3.4M
Current Assets
$5.1M
Current Liabilities
$4.3M
Debt
$3.9M
Debt Equity
$1.46
Equity
$2.7M
Interest Coverage
-11.05
Liabilities
$4.9M
Long Term Assets
$2.5M
Long Term Liabilities
$633,481
Net Cash
$-470,096
Net Cash By Market Cap
$-7.64
Net Debt Equity
$0.18
Tangible Book Value
$536,908
Tangible Book Value Per Share
$0.17
WACC
15.05

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.19
Inventory Turnover
0.01
Net Working Capital
$666,540
Quick ratio
0.8
Working Capital
$829,925
Working Capital Turnover
$0.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
-152.81%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
1Y total return
-43.93%
200-day SMA
2.95
3Y total return
-97.8%
50-day SMA
2.29
50-day SMA vs 200-day SMA
50under200
All Time High
600
All Time High Change
-99.68%
All Time High Date
2022-08-03
All Time Low
1.8
All Time Low Change
7.78%
All Time Low Date
2026-05-06
ATR
0.14
Beta
2.04
Beta1y
0.92
Beta2y
1.42
Ch YTD
-37.22
High
2.01
High52
6.47
High52 Date
2025-07-10
High52ch
-70.02%
Low
1.89
Low52
1.8
Low52 Date
2026-05-06
Low52ch
7.78%
Ma50ch
-15.17%
Premarket Change Percent
1.65
Premarket Price
$1.97
Premarket Volume
543
Price vs 200-day SMA
-34.33%
RSI
40.09
RSI Monthly
35.18
RSI Weekly
33.08
Sharpe ratio
-0.27x
Sortino ratio
-0.34
Total Return
-152.81%
Tr YTD
-37.22
Tr1m
-11.82%
Tr1w
-2.51%
Tr3m
-35.12%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

8
MetricValue
Analyst Count
1
Analyst Ratings
Strong Buy
Earnings EPS Estimate
$-1.12
Earnings Revenue Estimate
200,000x
Operating Income
$-7.8M
Operating margin
-89,939.6
Price target
$8
Price Target Change
$312

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

11
MetricValue
Float
3,071,908%
Float Percent
96.42%
Net Borrowing
2,300,254
Shares Insiders
3.58%
Shares Institutions
7.73%
Shares Out
3,186,094
Shares Qo Q
13.73%
Shares Yo Y
152.81%
Short Float
0.94%
Short Ratio
2.28
Short Shares
0.9

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

62
MetricValue
Adjusted FCF
$-8.4M
Average Volume
31,997.55x
Bv Per Share
0.83
CAPEX
$-3,554
Ch1m
-11.82
Ch1w
-2.51
Ch1y
-43.93
Ch3m
-35.12
Ch3y
-97.8
Ch6m
-25.67
Change
0%
Change From Open
-3.48
Close
1.94
Days Gap
3.61
Depreciation Amortization
28,546
Dollar Volume
32,152.7
Earnings Date
2026-03-16
Earnings Time
amc
EBIT
$-7.8M
EBITDA
$-7.8M
EPS
$-4.03
F Score
2
FCF
$-7.3M
FCF EV Yield
-110.95x
FCF Per Share
$-2.31
Financing CF
8,193,576
Fiscal Year End
April
Founded
2,007
Investing CF
-52,264
Ipr
-54.35
Iprfo
-99.48
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-03-16
Last Report Date
2026-01-31
Last Split Date
2024-05-17
Last Split Type
Reverse
Last10k Filing Date
2025-07-24
Ma150
2.77
Ma150ch
-30.06%
Ma20
2
Ma20ch
-3.19%
Net CF
800,513
Next Earnings Date
2026-07-23
Open
2.01
Optionable
No
Position In Range
41.67
Post Close
1.94
Postmarket Change Percent
-0.52
Postmarket Price
$1.93
Ppne
341,381
Pre Close
1.94
Price Date
2026-05-08
Ptbv Ratio
11.45
Relative Volume
0.52x
Revenue
8,669x
SBC By Revenue
12,498.41x
Share Based Comp
1,083,487
Tr6m
-25.67%
Us State
Texas
Volume
16,573.5
Z Score
-17.75
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does HSCS pay a dividend?

Capital-return profile for this ticker.

Performance

HSCS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-43.9%
S&P 500 1Y: n/a
3Y total return
-97.8%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns HSCS?

Insider, institutional, and short-interest positioning.

Institutional ownership
+7.7%
Float: +96.4% of shares outstanding
Insider ownership
+3.6%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+0.9%
2.3 days to cover
Y/Y dilution
+152.8%
Negative means the company is buying back shares.
Technical

HSCS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
40.1
Neutral momentum band
Price vs 200-day MA
-34.3%
50/200-day relationship not available
Beta (5Y)
2.04
More volatile than the market
Sharpe ratio
-0.27
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About HSCS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current HSCS stock rating?

HeartSciences Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full HSCS analysis?

The full report lives at /stocks/HSCS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for HSCS?

The latest report frames HSCS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the HSCS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.